These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5812106)

  • 1. Actions of some toxic substances (psychotomimetics) on the central nervous system.
    Bebbington A; Brimblecombe RW
    Br Med Bull; 1969 Sep; 25(3):293-8. PubMed ID: 5812106
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacology of hallucinogens.
    Brawley P; Duffield JC
    Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the central effects of psychodysleptics in rabbits and cats].
    Roche M
    C R Seances Soc Biol Fil; 1970; 164(4):864-9. PubMed ID: 4252163
    [No Abstract]   [Full Text] [Related]  

  • 4. [PHARMOLOGICAL STUDIES ON HALLUCINOGENS. 2. STUDIES ON THE EFFECT OF LSD25 ON THE CENTRAL NERVOUS SYSTEM].
    MATSUOKA M
    Nihon Yakurigaku Zasshi; 1964 Jan; 60():104-23. PubMed ID: 14156919
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysergic acid diethylamide (LSD) and tryptamine analogs as potential psychotomimetics.
    Liska KJ; Jain VO; Purich ED
    J Med Chem; 1968 Sep; 11(5):1105-6. PubMed ID: 5697093
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation of monoamines to mental disorders].
    Rysánek K
    Act Nerv Super (Praha); 1970; 12(2):97-108. PubMed ID: 4913937
    [No Abstract]   [Full Text] [Related]  

  • 7. On the conformations of hallucinogenic molecules and their correlation.
    Chothia C; Pauling P
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1063-70. PubMed ID: 4311249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methochlopramide and reagents of the central nervous system (mescaline, tryptamine, morphine, tremorine, nicotine)].
    Laville C; Margarit J
    Pathol Biol; 1965; 13(15):762-6. PubMed ID: 5321780
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of LSD on the central nervous system (review)].
    Popova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):457-62. PubMed ID: 4978646
    [No Abstract]   [Full Text] [Related]  

  • 11. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
    Bradley PB; Briggs I
    Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychopharmacology of hallucinogenic agents.
    Freedman DX
    Annu Rev Med; 1969; 20():409-18. PubMed ID: 4894506
    [No Abstract]   [Full Text] [Related]  

  • 15. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 16. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
    CURTIS DR
    Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological analysis of a specific cholinacetylase inhibitor].
    Stern P
    Arzneimittelforschung; 1971 Jul; 21(7):991-3. PubMed ID: 5109516
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 20. NBOMe - a very different kettle of fish . .
    Caldicott DG; Bright SJ; Barratt MJ
    Med J Aust; 2013 Sep; 199(5):322-3. PubMed ID: 23992179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.